LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method

Long non-coding RNAs (lncRNAs) have been demonstrated to play essential roles in diverse cellular processes and biological functions. Exploring the functions associated with lncRNAs may help provide insight into their underlying biological mechanisms. The current methods primarily focus on investigating the functions of individual lncRNAs; however, essential biological functions may be affected by the combinatorial effects of multiple lncRNAs. Here, we have developed a novel computational method, LncRNAs2Pathways, to identify the functional pathways influenced by the combinatorial effects of a set of lncRNAs of interest based on a global network propagation algorithm. A new Kolmogorov–Smirnov-like statistical measure weighted by the network propagation score, which considers the expression correlation among lncRNAs and coding genes, was used to evaluate the biological pathways influenced by the lncRNAs of interest. We have described the LncRNAs2Pathways methodology and illustrated its effectiveness by analyzing three lncRNA sets associated with glioma, prostate and pancreatic cancers. We further analyzed the reproducibility and robustness and compared our results with those of two other methods. Based on these analyses, we showed that LncRNAs2Pathways can effectively identify the functional pathways associated with lncRNA sets. Finally, we implemented this method as a freely available R-based tool.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  E. Kyle,et al.  Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. , 1997, Molecular pharmacology.

[3]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[4]  W. Cavenee,et al.  The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. , 1998, Cancer research.

[5]  G. Otsuka,et al.  Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells. , 1999, Cancer research.

[6]  G. Otsuka,et al.  Inhibition of Nuclear Factor-κB Activation Confers Sensitivity to Tumor Necrosis Factor-α by Impairment of Cell Cycle Progression in Human Glioma Cells , 1999 .

[7]  X. Ding,et al.  Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. , 1999, Biochemical and biophysical research communications.

[8]  Albert,et al.  Emergence of scaling in random networks , 1999, Science.

[9]  R. Agarwal,et al.  Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. , 2000, Biochemical pharmacology.

[10]  Ioannis Xenarios,et al.  DIP: The Database of Interacting Proteins: 2001 update , 2001, Nucleic Acids Res..

[11]  H. Habermann,et al.  Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer. , 2001, The Journal of urology.

[12]  David J. Galas,et al.  A duplication growth model of gene expression networks , 2002, Bioinform..

[13]  D. Danila,et al.  A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. , 2003, The Journal of clinical endocrinology and metabolism.

[14]  Adam J. Smith,et al.  The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..

[15]  Homin K. Lee,et al.  Coexpression analysis of human genes across many microarray data sets. , 2004, Genome research.

[16]  Ambuj K. Singh,et al.  Analysis of protein-protein interaction networks using random walks , 2005, BIOKDD.

[17]  P. Ritch,et al.  Neuregulin‐1 enhances survival of human astrocytic glioma cells , 2005, Glia.

[18]  Jubilee R. Stewart,et al.  Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells , 2005, Molecular Cancer Therapeutics.

[19]  Neil O. Carragher,et al.  The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.

[20]  C. O'Brian,et al.  Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells. , 2005, Molecular cancer therapeutics.

[21]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Sharan,et al.  Network-based prediction of protein function , 2007, Molecular systems biology.

[23]  J. Mohler,et al.  Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation , 2007, Proceedings of the National Academy of Sciences.

[24]  J. Condeelis,et al.  Regulation of the actin cytoskeleton in cancer cell migration and invasion. , 2007, Biochimica et biophysica acta.

[25]  W. Yung,et al.  Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo , 2007, Molecular Cancer Therapeutics.

[26]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.

[27]  K. Pienta,et al.  The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer* , 2008, Journal of Biological Chemistry.

[28]  Michael F. Lin,et al.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals , 2009, Nature.

[29]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[30]  Michael Q. Zhang,et al.  A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expression , 2010, EMBO Journal.

[31]  Daniel Normolle,et al.  Phenethyl Isothiocyanate Inhibits Oxidative Phosphorylation to Trigger Reactive Oxygen Species-mediated Death of Human Prostate Cancer Cells* , 2010, The Journal of Biological Chemistry.

[32]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[33]  Lee T. Sam,et al.  Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. , 2011, Genome research.

[34]  Shuli Kang,et al.  Large-scale prediction of long non-coding RNA functions in a coding–non-coding gene co-expression network , 2011, Nucleic acids research.

[35]  Hideaki Sugawara,et al.  The Sequence Read Archive , 2010, Nucleic Acids Res..

[36]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[37]  Wei Li,et al.  Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing , 2011, Proceedings of the National Academy of Sciences.

[38]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[39]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[40]  Kristopher Attwood,et al.  RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. , 2012, Molecular endocrinology.

[41]  A. Pandey,et al.  Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis. , 2012, Molecular bioSystems.

[42]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[43]  Anirban P. Mitra,et al.  A Central Role for Long Non-Coding RNA in Cancer , 2011, Front. Gene..

[44]  Jeannie T. Lee.  Epigenetic Regulation by Long Noncoding RNAs , 2012, Science.

[45]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[46]  L. Montanaro,et al.  Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. , 2012, Biochimica et biophysica acta.

[47]  A. Verma,et al.  Alterations in the ribosomal machinery in cancer and hematologic disorders , 2012, Journal of Hematology & Oncology.

[48]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[49]  J. Hou,et al.  Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. , 2013, The Journal of urology.

[50]  T. Jiang,et al.  MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas. , 2013, RNA.

[51]  David G Hendrickson,et al.  Differential analysis of gene regulation at transcript resolution with RNA-seq , 2012, Nature Biotechnology.

[52]  Ke Liu,et al.  Linc2GO: a human LincRNA function annotation resource based on ceRNA hypothesis , 2013, Bioinform..

[53]  Xiaoke Ma,et al.  Long non-coding RNAs function annotation: a global prediction method based on bi-colored networks , 2012, Nucleic acids research.

[54]  Hui Zhou,et al.  ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data , 2012, Nucleic Acids Res..

[55]  Yanyang Tu,et al.  Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma , 2014, Medical Oncology.

[56]  Yan Liu,et al.  High-resolution functional annotation of human transcriptome: predicting isoform functions by a novel multiple instance-based label propagation method , 2013, Nucleic acids research.

[57]  Xia Ying,et al.  Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence. , 2014, International journal of oncology.

[58]  Eugenia G. Giannopoulou,et al.  The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer , 2014, Nature Communications.

[59]  Sanghyuk Lee,et al.  lncRNAtor: a comprehensive resource for functional investigation of long non-coding RNAs , 2014, Bioinform..

[60]  N. Tran,et al.  Neurotrophin Signaling via TrkB and TrkC Receptors Promotes the Growth of Brain Tumor-initiating Cells* , 2014, The Journal of Biological Chemistry.

[61]  Ji-Lin Wang,et al.  A long non-coding RNA signature to improve prognosis prediction of colorectal cancer , 2014, Oncotarget.

[62]  A. Fatica,et al.  Long non-coding RNAs: new players in cell differentiation and development , 2013, Nature Reviews Genetics.

[63]  Fang Zhou,et al.  LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma , 2014, Gut.

[64]  A. Bhan,et al.  Long Noncoding RNAs: Emerging Stars in Gene Regulation, Epigenetics and Human Disease , 2014, ChemMedChem.

[65]  Xia Li,et al.  Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data , 2015, Database J. Biol. Databases Curation.

[66]  Marcel E. Dinger,et al.  lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs , 2014, Nucleic Acids Res..

[67]  J. Werner,et al.  Reduced retinoids and retinoid receptors' expression in pancreatic cancer: A link to patient survival , 2015, Molecular carcinogenesis.

[68]  Yun Liu,et al.  Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma. , 2015, Cancer genetics.

[69]  R. Kurokawa,et al.  Long Noncoding RNAs , 2015, Springer Japan.

[70]  Chunquan Li,et al.  A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways , 2015, Journal of The Royal Society Interface.

[71]  Jiajie Peng,et al.  LncRNA2Function: a comprehensive resource for functional investigation of human lncRNAs based on RNA-seq data , 2015, BMC Genomics.

[72]  W. Gong,et al.  Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e , 2016, Oncotarget.

[73]  Tin Chi Nguyen,et al.  Overcoming the matched-sample bottleneck: an orthogonal approach to integrate omic data , 2016, Scientific Reports.

[74]  K. Akashi,et al.  The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-). , 2016, Cancer research.

[75]  N. S. Yarla,et al.  Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. , 2016, Seminars in cancer biology.

[76]  Lin Gao,et al.  Advances in long noncoding RNAs: identification, structure prediction and function annotation , 2015, Briefings in functional genomics.

[77]  Fan Zhang,et al.  A network medicine approach to build a comprehensive atlas for the prognosis of human cancer , 2016, Briefings Bioinform..

[78]  I. Kovalenko,et al.  Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines , 2016, PloS one.

[79]  Peng Wang,et al.  Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers , 2015, Nucleic Acids Res..

[80]  Qiong Wang,et al.  Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway. , 2016, Acta biochimica et biophysica Sinica.

[81]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..